Pfizer plans to price its COVID-19 vaccine at $130 each when it hits the public market next year
This is a markup of over 10,000% compared to the estimated $1.18 it costs for the firm to develop the shot
While the firm did not receive US tax payer funds, its partner BioNTech took public money from Germany
The firm’s yearly revenue has more than doubled from 2019 to a projection of over $100billion this year
www.dailymail.co.uk/health/article-11357661/How-Pfizer-plans-sell-Covid-vaccine-10-000-markup.html
Not enough people are getting [vaccinated.] We’ve got to change that, so we can all have a safe and healthy holiday season.
BIDEN: "Not enough people are getting [vaccinated.] We've got to change that, so we can all have a safe and healthy holiday season." pic.twitter.com/TllJpDoJf9
— Breaking911 (@Breaking911) October 25, 2022